Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs
<p>Abstract</p> <p>Background</p> <p>CJ9-gD is a novel dominant-negative recombinant herpes simplex virus type 1 (HSV-1) that is completely replication-defective, cannot establish detectable latent infection <it>in </it>vivo, and expresses high levels of the...
Asıl Yazarlar: | Brans Richard, Yao Feng |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
BMC
2010-06-01
|
Seri Bilgileri: | BMC Microbiology |
Online Erişim: | http://www.biomedcentral.com/1471-2180/10/163 |
Benzer Materyaller
-
A herpes simplex virus 2 (HSV-2) glycoprotein D-expressing nonreplicating dominant-negative HSV-2 virus vaccine is superior to a gD2 subunit vaccine against HSV-2 genital infection in guinea pigs.
Yazar:: Pengwei Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01) -
An Adenovirus-Based Recombinant Herpes Simplex Virus 2 (HSV-2) Therapeutic Vaccine Is Highly Protective against Acute and Recurrent HSV-2 Disease in a Guinea Pig Model
Yazar:: Mingming Wan, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01) -
Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection
Yazar:: Kevin Egan, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01) -
Assessment of Two Novel Live-Attenuated Vaccine Candidates for Herpes Simplex Virus 2 (HSV-2) in Guinea Pigs
Yazar:: Jonathan D. Joyce, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01) -
Herpes Simplex Virus Mistyping due to HSV-1 × HSV-2 Interspecies Recombination in Viral Gene Encoding Glycoprotein B
Yazar:: Amanda M. Casto, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)